Sterling Global Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,830	Closed	-$200K	–	31
2017 Q1	$200K	Buy	+1,830	New	+$200K	0.97%	26